Related Experiment Videos

An oculocutaneous presentation of essential progressive telangiectasia

S Seiter, C Gantenbein, S Ugurel

The British Journal of Dermatology

|June 3, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCT.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025

Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial.

ESMO open·2025

Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

High efficacy of red light photodynamic therapy with 10 % aminolevulinic acid gel irrespective of the extent of keratinocyte atypia in actinic keratosis - exploratory post-hoc analysis of three pivotal phase III trials.

Photodiagnosis and photodynamic therapy·2024

Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial.

European journal of cancer (Oxford, England : 1990)·2023

Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

See all related articles